Hydroxyethyl Starch IV Solutions – Reliable Supply for Critical Care

Pharmaceutical-grade HES for plasma volume expansion. Factory-direct from Hebei, China. GMP compliant.

Why Sourcing Hydroxyethyl Starch IV Can Trip Up Importers

I've seen it happen more times than I can count. A procurement team in the US or Europe places an order for HES IV fluid components, excited about the price. Then the shipment arrives with inconsistent viscosity, or worse, batch variations that trigger stability issues in formulation. Suddenly, your hospital supply chain is delayed, and regulatory audits loom.

Supply inconsistencies top the list. Starch derivatives like hydroxyethyl starch aren't simple commodities. The degree of substitution (DS) and molar substitution (MS) directly impact plasma expansion efficacy and safety profiles. One off-spec batch, and you're reformulating or facing recalls.

Regulatory hurdles add another layer. FDA or EMA approvals demand GMP traceability. Many overseas suppliers cut corners on documentation, leaving buyers to chase certificates that never materialize. Lead times stretch from promised 4 weeks to 12, tying up capital in limbo.

Then there's hidden costs. Low-ball quotes often ignore molar mass distribution – critical for avoiding renal risks in patients. You end up paying premiums for rejections or secondary sourcing.

In my years exporting from Hebei, we've turned around dozens of these scenarios for US distributors. They come to us after bad experiences with fragmented suppliers in India or Eastern Europe. The fix? Partner with a factory that controls the entire hydroxyethyl starch production chain.

Short story: don't chase the cheapest quote. Prioritize MS 0.7-0.8 specs, full CoA per batch, and proven export compliance. It saves headaches down the line.

Our Hydroxyethyl Starch IV – Engineered for Reliability

Hydroxyethyl starch IV, or HES, has been a staple in critical care since the 1970s. At TANG ZHI TECHNOLOGY, we produce pharmaceutical-grade HES tailored for IV plasma expanders. Think Hetastarch equivalents or Voluven-like profiles: balanced colloid osmotic pressure without excessive accumulation.

Our standard offering is HES 130/0.4 – average molecular weight 130 kDa, molar substitution 0.4. This hits the sweet spot for short-term volume replacement in surgery, trauma, or sepsis. We've optimized etherification to ensure low free starch content (<0.1%), minimizing anaphylaxis risks.

What sets ours apart? Tight control on polydispersity index (PDI <1.5). This means predictable pharmacokinetics – faster clearance than high-MW alternatives, reducing ICU stays. Buyers in the US report seamless integration into their iso-oncotic solutions.

Production starts with potato starch hydrolysis, followed by ethylene oxide substitution under alkaline conditions. We use continuous reactors for uniformity, unlike batch methods that plague smaller factories. Post-processing includes dialysis for purity >99.5%.

Here's a quick spec overview:

hydroxyethyl starch hydroxyethyl starch hes 6 hydroxyethyl starch

Custom formulations? No problem. We adjust MS for sepsis-specific needs or lower Mw for pediatrics. All backed by full DMF filing support for your NDA.

Compared to competitors:

• Chinese generics: Often MS >0.5, higher accumulation risk.
• European brands: Premium pricing, 3x our MOQ.
• Indian suppliers: Variable PDI, frequent rejections.

We hit 20-30% cost savings for equivalent quality. Distributors confirm stable shelflife >36 months at ambient storage.

Real-World Applications in Critical Care

In surgical suites, HES IV shines for intraoperative hypovolemia. Perioperative blood loss control without albumin dependency. One US hospital chain uses our HES in elective ortho procedures – cuts crystalloid overload by half.

Burn units rely on it for early resuscitation. The colloid nature pulls fluid into vascular space faster than saline alone. We've supplied protocols matching Parkland formula adjustments.

Sepsis management? Balanced with balanced salt solutions, our low-Mw HES avoids the renal debates around high-Mw versions. Literature backs 6% infusions up to 50ml/kg/day safely.

Formulators appreciate the excipient versatility. Soluble in WFI, compatible with electrolytes, no phase separation in final bags.

Practical note: Always validate osmolarity in your mix. Ours clocks 280-300 mOsm/L, plug-and-play for most IV sets.

Inside Our Hebei Factory – Scale Meets Precision

TANG ZHI TECHNOLOGY (HeBei) CO., LTD sits on 140,000 sqm in Jinzhou, Hebei. Cleanrooms for pharma excipients span 90,000 sqm buildout. Annual HES capacity: 5,000 tons, part of our 40,000+ ton cellulose/starch lineup.

Equipment? Imported spray dryers from Germany, HPLC suites for MS verification. Full automation from starch slurry to powder isolation. This cuts contamination vectors – we've passed 15+ US FDA audits.

Certifications: GMP (China FDA), ISO 9001/15378, REACH pre-reg. DMF active for HES in US/EU markets. Export record: 50+ countries, including FDA-registered facilities.

Team of 20+ chemists fine-tune etherification ratios daily. Waste? Recycled via closed-loop – eco angle for your ESG reports.

Logistics – From Factory Gate to Your Dock

FOB Tianjin/Xingang, 25-35 days to US East Coast. 20ft container holds 18-20 tons HES powder. Drum packing: 25kg fiber drums, PE inner liner, palletized.

Stability data supports sea freight – no cold chain needed. Incoterms flexible: CIF, DAP for your preference.

Customs? We handle CoA, MSDS, fumigation certs. US importers note our HTSUS coding accuracy avoids duties snags.

MOQ 1 ton for trials. Payment: 30% TT advance, balance BL copy.

Procurement FAQs from Real Buyers

What Importers Say

John M., Pharma Distributor, Texas USA
"Sourced 2 tons for our contract manufacturer. Batches matched Voluven specs perfectly. No lot rejections, delivery on time. Pricing beat our previous Indian source by 25%."

Maria L., Hospital Group, UK
"Consistent MS 0.40 across 5 shipments. DMF helped our MHRA filing. Responsive engineers fixed a custom low-endotoxin request fast."

Raj P., IV Fluid Formulator, Canada
"PDI under 1.4 every time. Cut our QC testing time. Sea freight packaging held up – zero moisture ingress."

Dr. Elena K., Medical Devices, Australia
"From inquiry to delivery, professional. HES integrated seamlessly into our plasma expander line. Will reorder."

Ready to Secure Your HES IV Supply?

Eliminate sourcing risks. Get specs, samples, and pricing tailored to your needs.

+86-15032625168 | Contact Form